DeviceSpace.com
Medical Device and Diagnostics
News & Jobs
 
Search the Site
    
 
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login           Employers:  Register | Login  
 News | News By Subject | News By Date | Search News
Get Our Industry eNewsletter FREE email:    
 Print  Email    

Sirtex Medical Deal Elevated With Liver Cancer Therapy: Real M&A


9/17/2012 7:41:40 AM

A radiation treatment that attacks cancer in the liver from the inside is putting Sirtex Medical Ltd. (SRX) back into the takeover spotlight. Even after Sydney-based Sirtex’s earnings outpaced 99 percent of specialty pharmaceuticals companies in developed Asia in the past four years, according to data compiled by Bloomberg, profit may double by 2015 as more patients get Sirtex’s therapy, UBS AG estimates. The $494 million company is tripling manufacturing capacity in the U.S., its largest market, as it forecasts a “significant increase” in demand.

Read at Bloomberg

 Read Article at  Related Companies  News Categories
Bloomberg
   


ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 
    

//-->